Researchers have developed a light-activated tool to show how drugs need to be adapted to combat type 2 diabetes.
Compounds that stop a cellular rescue operation for stuck ribosomes may bolster the nation's defenses against biowarfare and bioterrorism, as well as create alternative antibiotics to handle increasingly resistant pathogens, ...
Scientists at Trinity College Dublin have provided the first crystal clear molecular blueprint of Globomycin - an antibacterial candidate with promise in stemming the onrushing post-antibiotic tide.
How information is transferred from biological molecules to crystalline surfaces could pave the way for the development of new drugs and other synthetic materials.
Scientists in the United States said Tuesday they were developing a faster, more efficient way of gauging the toxicity of chemicals, which may reduce the need for animal testing.
A team at Griffith University's Institute for Glycomics has made a scientific discovery that will change the way scientists explore vaccine development and drug discovery for infectious diseases.
A team of scientists, including several from the U.S. Department of Energy's Argonne National Laboratory, have determined the structures of several important tuberculosis enzymes, which could lead to new drugs for the disease.
Researchers have developed a new technique to produce a 3D 'micro-printed' array of needles capable of drug delivery. The technique would offer a pain-free drug delivery device that would allow drugs to diffuse within the ...
Clinical trials of new drugs or devices face a problem that most empirical inquiries don't: They must not only provide clear data about toxicity and efficacy but also try to maximize the quality of treatment for all of the ...
Infections with one of the most troublesome and least understood antibiotic-resistant "superbugs" are increasing at alarming rates, particularly in health-care settings.